Search
Supernus Pharmaceuticals Inc
SUPNAdd to Watchlist
27.620USD
+1.460+5.58%
Close 11-09 16:00（ET）
1.61BMarket Cap
LossP/E TTM
Today
+5.58%
5 Days
-18.26%
1 Month
-19.70%
6 Months
-33.50%
Year to Date
-31.06%
1 Year
-25.54%
Key Figures
27.045Open
27.910High
260.13KVolume
LossP/E TTM
3.36P/E Dynamic
--Dividend TTM
0.45%Turnover Ratio
26.160Prev. Close
26.110Low
7.15MTurnover
21.80P/E Static
-26.84P/B
0.00%Div Yield TTM
-2.04%ROA
48.10652wk High
0.04Volume Ratio
73.86MNet Profit
58.24MShares
-0.5110EPS TTM
0.55Beta
-2.75%ROE
25.92052wk Low
7.53%Amplitude
86.91%Gross Margin
1.61BMarket Cap
0.94Reward/Risk
2.94%Risk Rate
Supernus Pharmaceuticals Inc's Score
0.19vs previous score
Forecast8.00
Financial Health8.49
Technical4.91
Valuation Dimensions9.10
Institutional Confidence10.00
Risk Assessment3.88
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
Supernus Pharmaceuticals Inc Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Strong sell
Supernus Pharmaceuticals Inc Latest Earnings Call Transcripts
Supernus Pharmaceuticals (SUPN) Q3 2026 Earnings Call: Revenue Growth, Higher Guidance and Indivior Merger
Supernus Pharmaceuticals’ Q3 2026 earnings call covered 18% revenue growth, stronger product sales, raised standalone guidance and the pending Indivior merger.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
1.16/0.49
Revenue / Forecast
356.00M/215.92M
Supernus Pharmaceuticals Inc Profile
SectorPharmaceuticals
Ticker SymbolSUPN
Number of employees674
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| BlackRock Institutional Trust Company, N.A. | 13.47% |
| Millennium Management LLC | 5.65% |
| Vanguard Portfolio Management, LLC | 5.58% |
| Armistice Capital LLC | 4.76% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 48.46% |
| Investment Advisor/Hedge Fund | 26.81% |
| Hedge Fund | 21.60% |
| Individual Investor | 4.46% |
Related Instruments
+4.28%
+2.13%
+0.68%
+1.38%
+0.70%
+1.59%
+1.04%
+1.46%
+2.65%
-0.54%
+0.69%
0.00%
-0.14%
+2.30%
+5.83%
+2.40%
+1.73%
+0.33%
+0.95%
+3.78%
FAQs
What is the current price of Supernus Pharmaceuticals Inc (SUPN)?
The current price of Supernus Pharmaceuticals Inc (SUPN) is 27.62.
What is the symbol of Supernus Pharmaceuticals Inc?
The ticker symbol of Supernus Pharmaceuticals Inc is SUPN.
What is the 52-week high of Supernus Pharmaceuticals Inc?
The 52-week high of Supernus Pharmaceuticals Inc is 48.11.
What is the 52-week low of Supernus Pharmaceuticals Inc?
The 52-week low of Supernus Pharmaceuticals Inc is 25.92.
What is the market capitalization of Supernus Pharmaceuticals Inc?
The market capitalization of Supernus Pharmaceuticals Inc is 1.61B.
What is the Earnings Per Share (EPS TTM) of Supernus Pharmaceuticals Inc (SUPN)?
The Earnings Per Share (EPS TTM) of Supernus Pharmaceuticals Inc (SUPN) is -0.51.